EPTIS
BAM Logo

Parasite serology: Toxoplasma gondii

[Parazita szerológia: Toxoplasma gondii]

EPTIS Ringversuch Nr. 1278388 | Letze Änderung 2024-10-21 | URL: https://www.eptis.bam.de/pts1278388 https://www.eptis.bam.de/pts1278388

Name des Anbieters
Name des Anbieters QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Ansässig in Hungary
Sprache(n) English, Hungarian
Anmerkungen Qualitative results are evaluated in the scheme.
Klassifizierung
Produktgruppen Health care / medical devices
Human test material
Prüfgebiete Medical analysis
Technische Einzelheiten
Prüfobjekt Prüfeigenschaft Prüfmethode
2 samples of 1 mL lyophilised serum each Toxoplasmosis IgG Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis IgM Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis IgA Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis polyvalent Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasmosis avidity Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Toxoplasma gondii interpretation Chemiluminescence (ChLIA), enhanced chemiluminescence immunoassay (ECI)
Chemiluminescence magnetic microparticle immunoassay (CLMIA)
Direct Agglutination
Electro chemiluminescence immunoassay (ECLIA)
ELFA-technology (Enzyme Linked Fluroescence Assay)
Enzyme immunoassay: heterogeneous methods (EIA, ELISA)
Immune fluorescence test (IFT)
Immunoblot (Western Blot)
ISAGA (Immunosorbent Agglutination Assay)
KBR
Latex Agglutination
Luminescence enhanced enzyme immunoassays (LEIA, LIEMA)
MEIA
Ringversuchsziele
Zielgruppe des Ringversuchs In vitro medical laboratories
Relevante Rechtsvorschriften oder Normen ILAC_G8:09/2019 – Guidelines on Decision Rules and Statements of Conformity ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances
Weitere Ziele validation of testing methods
Teilnehmerzahl
Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt)
Die Durchführung des Ringversuchs ist in Auftrag gegeben durch
Kosten
Teilnahmegebühr on demand
Regelmässig durchgeführt Ja (four times a year)
Der Ringversuch wird durchgeführt seit
Kontaktdaten des Anbieters
Anbieter Kontaktperson
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Feketesas u. 19-21. I/7
6720 Szeged
Hungary

Telefon: +36 30 462 5864
Fax:
Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html
Ms. Eszter Mezey
Telefon: +36 30 462 5864
Fax:
E-Mail: mail@qualicont.com mail@qualicont.com
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für Hungary, Ms Eszter Mezey. Ms Eszter Mezey.
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5